DK1135164T3 - Sammensætning til behandling af inflammation - Google Patents
Sammensætning til behandling af inflammationInfo
- Publication number
- DK1135164T3 DK1135164T3 DK99957793T DK99957793T DK1135164T3 DK 1135164 T3 DK1135164 T3 DK 1135164T3 DK 99957793 T DK99957793 T DK 99957793T DK 99957793 T DK99957793 T DK 99957793T DK 1135164 T3 DK1135164 T3 DK 1135164T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammation
- treatment
- composition
- bcc
- mcc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11094398P | 1998-12-04 | 1998-12-04 | |
| EP99957793A EP1135164B1 (de) | 1998-12-04 | 1999-12-03 | Zusammensetzung zur behandlung von entzündungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1135164T3 true DK1135164T3 (da) | 2004-12-20 |
Family
ID=22335783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99957793T DK1135164T3 (da) | 1998-12-04 | 1999-12-03 | Sammensætning til behandling af inflammation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6890911B1 (de) |
| EP (1) | EP1135164B1 (de) |
| JP (2) | JP4488626B2 (de) |
| AT (1) | ATE273027T1 (de) |
| AU (1) | AU768327B2 (de) |
| CA (1) | CA2354047C (de) |
| DE (1) | DE69919386T2 (de) |
| DK (1) | DK1135164T3 (de) |
| ES (1) | ES2226464T3 (de) |
| PT (1) | PT1135164E (de) |
| WO (1) | WO2000033879A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG189365A1 (en) | 2010-10-13 | 2013-05-31 | Bioniche Urology Ip Inc | Compositions de membranes cellulaires et d'acide ribonucléique bactériens, et leurs procédés de fabrication et d'utilisation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71683A0 (en) * | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
| JPH0517363A (ja) * | 1991-07-11 | 1993-01-26 | Yakult Honsha Co Ltd | 抗炎症剤及びそれを含有する化粧料 |
| JPH08508976A (ja) * | 1993-01-29 | 1996-09-24 | ベトレフアーム・インコーポレーテツド | 改善化免疫療法用組成物 |
| EP0971720A1 (de) * | 1997-04-02 | 2000-01-19 | Bioniche Inc. | Verwendung von extrakte von bakteriellen zellwände zur behandlung von topischen krankheiten und wunden |
| HU227921B1 (hu) * | 1997-08-05 | 2012-06-28 | Bioniche Life Sciences Inc | Készítmény és eljárás sejtproliferáció és sejtpusztulás szabályozására |
| DE60020352T2 (de) * | 1999-04-01 | 2005-10-20 | Bioniche Life Science, Inc., Belleville | Zusammensetzung und Methode zur Inuzierung von Apptosis in Prostatakrebszellen mittels M-DNA und MCC |
-
1999
- 1999-12-03 EP EP99957793A patent/EP1135164B1/de not_active Expired - Lifetime
- 1999-12-03 DE DE69919386T patent/DE69919386T2/de not_active Expired - Lifetime
- 1999-12-03 AT AT99957793T patent/ATE273027T1/de active
- 1999-12-03 US US09/857,333 patent/US6890911B1/en not_active Expired - Fee Related
- 1999-12-03 ES ES99957793T patent/ES2226464T3/es not_active Expired - Lifetime
- 1999-12-03 PT PT99957793T patent/PT1135164E/pt unknown
- 1999-12-03 DK DK99957793T patent/DK1135164T3/da active
- 1999-12-03 CA CA002354047A patent/CA2354047C/en not_active Expired - Fee Related
- 1999-12-03 AU AU15411/00A patent/AU768327B2/en not_active Ceased
- 1999-12-03 WO PCT/CA1999/001156 patent/WO2000033879A1/en active IP Right Grant
- 1999-12-03 JP JP2000586369A patent/JP4488626B2/ja not_active Expired - Fee Related
-
2009
- 2009-10-02 JP JP2009230708A patent/JP5050148B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69919386D1 (de) | 2004-09-16 |
| PT1135164E (pt) | 2004-11-30 |
| EP1135164B1 (de) | 2004-08-11 |
| US6890911B1 (en) | 2005-05-10 |
| AU1541100A (en) | 2000-06-26 |
| JP5050148B2 (ja) | 2012-10-17 |
| WO2000033879A1 (en) | 2000-06-15 |
| AU768327B2 (en) | 2003-12-11 |
| CA2354047A1 (en) | 2000-06-15 |
| CA2354047C (en) | 2007-08-14 |
| JP2010001314A (ja) | 2010-01-07 |
| DE69919386T2 (de) | 2005-02-17 |
| JP2002531528A (ja) | 2002-09-24 |
| ES2226464T3 (es) | 2005-03-16 |
| EP1135164A1 (de) | 2001-09-26 |
| JP4488626B2 (ja) | 2010-06-23 |
| ATE273027T1 (de) | 2004-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL180924A0 (en) | Method for regulating cell proliferation and cell death | |
| YU48701A (sh) | Fenilfenantridini sa dejstvom inhibicije pde-iv | |
| TR200103428T2 (tr) | IMPDH enzim inhibitörleri. | |
| BR9913532A (pt) | Novos inibidores heteroaromáticos de frutose 1,6-bifosfatase | |
| MY120235A (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| ES2150157T3 (es) | Piridinas 2-aril sustituidas. | |
| TR200101339T2 (tr) | Potasyum kanal modülatörleri olarak 3-yer-alanlı-4-arilkinolin-2-on türevleri, 3,4-okzadiazolon türevleri | |
| BR0010220A (pt) | Compostos de pirimidinona | |
| DE60116642D1 (de) | Verbindungen mit cytochrom p450ra1 hemmenden aktivität | |
| PT1147087E (pt) | Feantridina-n-oxidos com actividade de inibicao de pde-iv | |
| DK1135164T3 (da) | Sammensætning til behandling af inflammation | |
| MY134896A (en) | Therapeutic agent for hepatitis | |
| TR200103004T2 (tr) | Pirolidinkarbonilamino siklik disülfitler. | |
| DK1054680T3 (da) | Behandling af blærecancer med mycobacterium phlei cellevæg | |
| AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. | |
| WO2004012652A3 (en) | Treatment of multiple sclerosis with brain targeted anti oxidant compounds | |
| IS4935A (is) | Hagnýting T-Bam (CD40L) tækni til meðferðar við sjúkdómum sem sléttvöðvafrumur eiga þátt í | |
| ATE267804T1 (de) | Alpha-(2-hydroxyphenyl)nitrone, diese enthaltenden pharmazeutische zubereitungen sowie deren verwendung zur behandlung von entzündungen | |
| EP1165106B8 (de) | Zusammensetzung und methode zur induzierung von apoptosis in prostatakrebszellen mittels m-dna und mcc | |
| DE69902999D1 (de) | Glucocorticoide zur behandlung von glomerulonephitis | |
| MX9805724A (es) | Aplicaciones terapeuticas de la tecnologia t-bam (cd40-l) para tratar enfermedades inflamatorias del riñon que tienen puntos de iniciacion diferentes de la deposicion de autoanticuerpos. | |
| ATE276766T1 (de) | Chemotherapeutische zusammensetzung und verfahren | |
| TR200102019T2 (tr) | 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları. | |
| AU758194C (en) | Novel benzimidazoles and benzoxazoles | |
| GEP20012440B (en) | Biphenylsulfonamide Matrix Metalloproteinase Inhibitors |